These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 34193749)

  • 1. Rapid evolution of the COVID-19 pandemic calls for a unified public health response.
    He N
    Biosci Trends; 2021 Sep; 15(4):196-200. PubMed ID: 34193749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 transmissibility compared between variants of concern and vaccination status.
    Wang L; Didelot X; Bi Y; Gao GF
    Brief Bioinform; 2022 Mar; 23(2):. PubMed ID: 35062017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 - Important considerations for developing and using a vaccine.
    Rahman IU; Ali N; Ijaz F; Afzal A; Abd Allah EF
    Hum Vaccin Immunother; 2021 Feb; 17(2):414-415. PubMed ID: 32693665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward Achieving a Vaccine-Derived Herd Immunity Threshold for COVID-19 in the U.S.
    Gumel AB; Iboi EA; Ngonghala CN; Ngwa GA
    Front Public Health; 2021; 9():709369. PubMed ID: 34368071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A COVID-19 vaccine-dare to dream.
    Phillis A
    Br J Community Nurs; 2020 Dec; 25(12):2-7. PubMed ID: 33275510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 vaccines: concerns beyond protective efficacy and safety.
    Lai CC; Chen IT; Chao CM; Lee PI; Ko WC; Hsueh PR
    Expert Rev Vaccines; 2021 Aug; 20(8):1013-1025. PubMed ID: 34180347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The COVID-19 Vaccination and Vaccine Inequity Worldwide: An Empirical Study Based on Global Data.
    Ning C; Wang H; Wu J; Chen Q; Pei H; Gao H
    Int J Environ Res Public Health; 2022 Apr; 19(9):. PubMed ID: 35564661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herd immunity: challenges and the way forward in Korea.
    Oh J; Kim S; Ryu B; Shin M; Kim BI
    Epidemiol Health; 2021; 43():e2021054. PubMed ID: 34412446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virology, epidemiology, immunology and vaccine development of SARS-CoV-2, update after nine months of pandemic.
    Baay M; Lina B; Fontanet A; Marchant A; Saville M; Sabot P; Vandeputte J; Neels P
    Biologicals; 2021 Jan; 69():76-82. PubMed ID: 33234420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonpharmaceutical Interventions Used to Control COVID-19 Reduced Seasonal Influenza Transmission in China.
    Lei H; Xu M; Wang X; Xie Y; Du X; Chen T; Yang L; Wang D; Shu Y
    J Infect Dis; 2020 Nov; 222(11):1780-1783. PubMed ID: 32898256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Public health and social measures to mitigate the health and economic impact of the COVID-19 pandemic in Turkey, Egypt, Ukraine, Kazakhstan, and Poland during 2020-2021: situational analysis.
    Kitamura N; Abbas K; Nathwani D
    BMC Public Health; 2022 May; 22(1):991. PubMed ID: 35578330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 vaccine challenges: What have we learned so far and what remains to be done?
    Forman R; Shah S; Jeurissen P; Jit M; Mossialos E
    Health Policy; 2021 May; 125(5):553-567. PubMed ID: 33820678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonpharmaceutical interventions in Turkey and worldwide during COVID-19 pandemic.
    Ilhan MN; Tüzün H; Kiliç R; Yildirim N
    Turk J Med Sci; 2021 Dec; 51(SI-1):3207-3214. PubMed ID: 34590802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid relaxation of pandemic restrictions after vaccine rollout favors growth of SARS-CoV-2 variants: A model-based analysis.
    Van Egeren D; Stoddard M; Novokhodko A; Rogers MS; Joseph-McCarthy D; Zetter B; Chakravarty A
    PLoS One; 2021; 16(11):e0258997. PubMed ID: 34818335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Looking beyond COVID-19 as a pandemic.
    Lau YL
    Hong Kong Med J; 2021 Apr; 27(2):88-89. PubMed ID: 33843608
    [No Abstract]   [Full Text] [Related]  

  • 16. Vaccination as an alternative to non-drug interventions to prevent local resurgence of COVID-19.
    Pan J; Zhu W; Tian J; Liu Z; Xu A; Yao Y; Wang W
    Infect Dis Poverty; 2022 Mar; 11(1):36. PubMed ID: 35346382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Social Workers and the National Strategy for the COVID-19 Response and Pandemic Preparedness.
    Evans EJ
    Health Soc Work; 2021 Jun; 46(2):89-91. PubMed ID: 33930125
    [No Abstract]   [Full Text] [Related]  

  • 18. Delayed Access to COVID-19 Vaccines: A Perspective on Low-income Countries in Africa.
    Hassan MA; Aliyu S
    Int J Health Serv; 2022 Jul; 52(3):323-329. PubMed ID: 35469499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of COVID-19: current status and future prospects.
    Kabir MA; Ahmed R; Chowdhury R; Iqbal SMA; Paulmurugan R; Demirci U; Asghar W
    Microbes Infect; 2021; 23(4-5):104832. PubMed ID: 33872807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 evolution during the pandemic - Implications of new SARS-CoV-2 variants on disease control and public health policies.
    van Oosterhout C; Hall N; Ly H; Tyler KM
    Virulence; 2021 Dec; 12(1):507-508. PubMed ID: 33494661
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.